ALETHIA BIOTHERAPEUTICS

Alethia BioTherapeutics, Inc., a biotechnology company, engages in the discovery and development of monoclonal antibody-based therapeutics focusing on the cancer-associated epithelial-to-mesenchymal transition, ovarian cancer, and on cancer-induced bone loss. Its products include Isogranulatimide, a G2 checkpoint inhibitor, which potentiates the response to several DNA-damaging chemotherapeutic agents; sCLU, a heterodimeric disulphide-linked glycoprotein of 449 amino acids, the over-expression o... f which is observed in various malignancies, including prostate, bladder, kidney, breast, colon, and lung tumors; AB-0447, an antigen that is expressed at the surface of ovarian cancer epithelial cells in greater than eighty five percent of malignant tumors; and AB-0440, a cell-surface protease-like protein, whose expression is stimulated early in osteoclast differentiation in response to RANK ligand. The company was founded in 2002 and is based in Montreal, Canada.

#SimilarOrganizations #People #Financial #Website #More

ALETHIA BIOTHERAPEUTICS

Industry:

Biotechnology Health Care Therapeutics

Founded:

2002-01-01

Address:

Montréal, Quebec, Canada

Country:

Canada

Website Url:

http://www.alethiabio.com

Total Employee:

11+

Status:

Active

Contact:

514-858-7666

Email Addresses:

[email protected]

Total Funding:

20.28 M USD

Technology used in webpage:

SPF Google Font API Google Analytics WordPress Wordpress Plugins Microsoft Exchange Online Office 365 Mail AJAX Libraries API PHP Google Analytics Classic

Similar Organizations

ablexis-logo

Ablexis

Ablexis is a biotechnology company developing an innovative, next-generation platform for antibody drug discovery.

aerpio-pharmaceuticals-logo

Aerpio Pharmaceuticals

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

biogen-idec-logo

Biogen Idec

Biogen Idec is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

enosi-life-sciences-logo

Enosi Life Sciences

Enosi Life Sciences is a drug research and development company providing therapeutics for autoimmune diseases and cancer.

heron-therapeutics-logo

Heron Therapeutics

Heron Therapeutics is a biotechnology firm specializing in polymer-based pharmaceuticals.

interx-logo

InterX

InterX, Inc. is a biotechnology startup revolutionizing biomolecular computation.

milestone-pharmaceuticals-logo

Milestone Pharmaceuticals

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

neurotech-logo

Neurotech

Neurotech is a biotechnology company developing sight-saving therapeutics for chronic retinal diseases.

novelmed-therapeutics-logo

NovelMed Therapeutics

NovelMed Therapeutics is a biotechnology company developing novel therapies for orphan and non-orphan diseases.

oceana-therapeutics-logo

Oceana Therapeutics

Oceana Therapeutics is a global company committed to commercializing best-in-class therapeutics with a focus on colorectal,

planet-biotechnology-logo

Planet Biotechnology

Planet Biotechnology is a clinical-stage company that develops monoclonal antibody-based therapeutic and preventative products.

protiva-biotherapeutics-logo

Protiva Biotherapeutics

Protiva Biotherapeutics is a biotechnology company developing nucleic acid based pharmaceutical products.

rewrite-therapeutics-logo

Rewrite Therapeutics

Rewrite Therapeutics is a private biotechnology company focused on advancing novel DNA writing technologies.

Current Advisors List

ela-borenstein_image

Ela Borenstein Board Member @ Alethia BioTherapeutics
Board_member

louis-lacasse_image

Louis Lacasse Board of Directors @ Alethia BioTherapeutics
Board_member

Current Employees Featured

not_available_image

Julie Laurin
Julie Laurin Vice President, Drug Development @ Alethia BioTherapeutics
Vice President, Drug Development
2021-01-01

richard-r-lesniewski_image

Richard R. Lesniewski
Richard R. Lesniewski Scientific Advisory Board @ Alethia BioTherapeutics
Scientific Advisory Board

yves-cornellier_image

Yves Cornellier
Yves Cornellier President and CEO @ Alethia BioTherapeutics
President and CEO
2005-04-01

mario-filion_image

Mario Filion
Mario Filion Co-Founder, Executive Vice President & Chief Scientific Officer @ Alethia BioTherapeutics
Co-Founder, Executive Vice President & Chief Scientific Officer
2002-10-01

jacques-jolivet_image